Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001947620-25-000003
Filing Date
2025-08-05
Accepted
2025-08-05 13:31:43
Documents
1
Effectiveness Date
2025-08-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8469
  Complete submission text file 0001947620-25-000003.txt   9606
Mailing Address 75 KNEELAND STREET 14TH FLOOR BOSTON MA 02111
Business Address 75 KNEELAND STREET 14TH FLOOR BOSTON MA 02111 1 (617) 766-3909
Lapix Therapeutics Inc. (Filer) CIK: 0001947620 (see all company filings)

EIN.: 842410144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-553733 | Film No.: 251184082